Skip to content

Spironolactone/​Hydrochlorothiazide

    DEA Class; Rx

    Common Brand Names; Aldactazide

    • Thiazide Combos

    Combination oral diuretic product; potassium-sparing diuretic (aldosterone antagonist) and thiazide diuretic
    For treatment of hypertension or edema (not initial treatment)
    Useful for patients with hyperaldosteronism or hypokalemia

    Indicated for the treatment of edema associated with cirrhosis of the liver, congestive heart failure, or the nephrotic syndrome.
    For the treatment of essential hypertension.
    For the treatment of chronic lung disease (CLD).

    Hypersensitivity to spironolactone, hydrochlorothiazide, or sulfonamides

    Acute renal failure

    Acute/severe hepatic failure

    Anuria

    Hyperkalemia

    Addison’s disease or other conditions associated with hyperkalemia

    Coadministration with eplerenone

    Spironolactone

    • Drowsiness
    • Lethargy
    • Headache
    • Stevens-Johnson Syndrome
    • Rash
    • Urticaria
    • Gynecomastia
    • Impotence
    • Menstrual disorders
    • Abdominal cramping
    • Diarrhea
    • Gastritis
    • Nausea/vomiting
    • Drug rash with eosinophilia and systemic symptoms (DRESS)
    • Toxic epidermal necrolysis

    Hydrochlorothiazide

    • Anorexia
    • Epigastric distress
    • Hypotension
    • Orthostatic hypotension
    • Photosensitivity
    • Anaphylaxis
    • Anemia
    • Confusion
    • Erythema multiforme
    • Stevens-Johnson syndrome
    • Exfoliative dermatitis including toxic epidermal necrolysis
    • Hypomagnesemia
    • Dizziness
    • Headache
    • Hyperuricemia

    Somnolence and dizziness reported

    Caution with hepatic impairment

    Spironolactone

    • May cause hyperkalemia; risk may be increased in patients with renal insufficiency, diabetes mellitus, or if coadministered with other drugs/diet that raise serum potassium levels
    • Gynecomastia reported

    Hydrochlorothiazide

    • May cause hypokalemia and hyponatremia; risk of hypokalemia may be increased in patients with cirrhosis, brisk diuresis, or if coadministered with other drugs that lower serum potassium
    • May cause hypomagnesemia, which can then result in hypokalemia which appears difficult to treat despite potassium repletion
    • May alter glucose tolerance and increase risk for hyperglycemia
    • May increase serum levels of calcium and uric acid by decreasing urinary excretion; may also increase cholesterol and triglycerides
    • Thiazides diuretics may add to or potentiate the action of other antihypertensive drugs
    • Sensitivity reactions to thiazides may occur in patients with or without a history of allergy or bronchial asthma
    • Sulfonamide derivatives, including thiazides, have been reported to exacerbate or activate systemic lupus erythematosus
    • Instruct patients to protect skin from sun and undergo regular skin cancer screening
    • Angle-closure glaucoma

    Pregnancy Category: C

    Lactation: discontinue drug or do not nurse

    Adults

    200 mg/day PO spironolactone and 200 mg/day PO hydrochlorothiazide.

    Geriatric

    200 mg/day PO spironolactone and 200 mg/day PO hydrochlorothiazide.

    Adolescents

    Safety and efficacy have not been established.

    Children

    Safety and efficacy have not been established.

    Infants

    Safety and efficacy have not been established.

    Spironolactone/hydrochlorothiazide

    tablet

    • 25mg/25mg
    • 50mg/50mg